Ray Studios runs a growing network of medical tattoo-removal studios across France, Spain, and Belgium, delivering treatments under doctor supervision with picosecond lasers such as the PicoWay. Its proprietary Ray Studios Advanced Performance (RsAP) methodology aims to shorten treatment time, improve outcomes, and boost safety. Over the past 12 months the company more than doubled both its revenue and its physical footprint, now operating 20 studios. Ray Studios has also launched an AI-powered medical decision-support agent and the first dedicated tattoo-removal follow-up app to enhance diagnostic precision and patient engagement. The firm plans to use new capital to more than double its studio network again within the next two years. Additional funds will be directed toward further clinical research, medical leadership, and technology upgrades that optimize treatment protocols and patient experience.

Total raised

$15M

Funding rounds

2

Latest round

Equity

Latest activity

Dec 2025